Yorsua, Ecyl Joy .
HRN: 22-70-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/09/2023
CO-AMOXICLAV 625MG (TAB)
03/09/2023
03/16/2023
PO
625 Mg
BID
S/P Episiorrhaphy
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes